RISK-FACTORS FOR KIDNEY CANCER IN NEW-SOUTH-WALES, AUSTRALIA .2. UROLOGIC DISEASE, HYPERTENSION, OBESITY, AND HORMONAL FACTORS

被引:105
作者
MCCREDIE, M
STEWART, JH
机构
关键词
AUSTRALIA; BETA-BLOCKERS; CASE-CONTROL STUDY; DIURETICS; HYPERTENSION; KIDNEY CANCER; OBESITY; POPULATION-BASED; RENAL CELL CANCER; RENAL PELVIC CANCER; UROLOGIC DISEASE;
D O I
10.1007/BF00146885
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a population-based case-control study of kidney cancer in New South Wales, Australia, data from structured interviews with 489 cases of renal cell cancer (RCC) and 147 cases of renal pelvic cancer (CaRP) diagnosed in 1989 and 1990, and 523 controls from the electoral rolls, confirmed the link between obesity and RCC. In addition, regular consumption of 'diet' pills independently increased the risk for this cancer. A diagnosis of hypertension at least two years before interview raised the risk for RCC, and regular use of beta-blockers, a class of antihypertensive drug, independently increased the risk for RCC and CaRP (risk ratio = 1.5-1.8). No independent effect was found for use of diuretics. Additional information provided by this study includes increased risks associated with kidney injury (RCC, CaRP)-possibly attributed to recall bias-and kidney infection (CaRP), as well as a nonsignificantly raised risk linked with kidney stones (RCC, CaRP) and a significantly reduced risk for RCC in persons giving a history of lower urinary tract infection. No significant association of RCC was found with hormonal factors (age at menarche or menopause; child-bearing; regular use of oral contraceptives or estrogens; hysterectomy or oophorectomy).
引用
收藏
页码:323 / 331
页数:9
相关论文
共 34 条
[1]  
McLaughlin J.K., Mandel J.S., Blot W.J., Schuman L.M., Mehl E.S., Fraumeni J.F., A population-based case-control study of renal cell carcinoma, JNCI, 72, pp. 275-84, (1984)
[2]  
Talamini R., Baron A.E., Barra S., Et al., A case-control study of risk factor for renal cell cancer in northern Italy, Cancer Causes Control, 1, pp. 125-31, (1990)
[3]  
McCredie M., Ford J.M., Stewart J.H., Risk factors for cancer of the renal parenchyma, Int J Cancer, 42, pp. 13-6, (1988)
[4]  
Asal N.R., Geyer J.R., Risser D.R., Lee E.T., Kadamani S., Cherng N., Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions, Cancer Det Prev, 13, pp. 263-79, (1988)
[5]  
McCredie M., Stewart J.H., Carter J.J., Turner J., Mahony J.F., Phenacetin and renal papillary necrosis: Independent risk factors for renal pelvic cancer, Kidney Int, 30, pp. 81-4, (1986)
[6]  
Yu M.C., Mack T.M., Hanisch R., Cicioni C., Henderson B.E., Cigarette smoking, obesity, diuretic use, and coffee consumption as risk factors for renal cell carcinoma, JNCI, 77, pp. 351-6, (1986)
[7]  
McLaughlin J.K., Blot W.J., Fraumeni J.F., Diuretics and renal cell cancer, JNCI, 80, (1988)
[8]  
Wynder E.L., Mabuchi K., Whitmore W.F., Epidemiology of adenocarcinoma of the kidney, JNCI, 53, pp. 1619-34, (1974)
[9]  
Fraser G.E., Phillips R.L., Beeson W.L., Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-day Adventists, Int J Epidemiol, 19, pp. 832-8, (1990)
[10]  
McCredie M., Stewart J.H., Ford J.M., MacLennan R.A., Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women, Br J Urol, 55, pp. 220-4, (1983)